EPFL Investor Day 2024

10 Dec 2024 | Lausanne, Switzerland

Frédérik Plourde

CEO & Co-founder

Neuria SA

Fribourg, Switzerland

25 profile visitsSpeaker

3-times founder with 10+ years of experience in leading startups, with a focus on digital health solutions, and a successful exit in the field.

My organisation

Neuria SA

Neuria SA

Startup

Fribourg, Switzerland

Neuria offers a scientifically validated, scalable digital intervention that targets food cravings at their root, improving outcomes for millions at risk of living with overweight, obesity or T2D. Our 15+ years of fundamental and clinical research has demonstrated that playing our digital intervention for 15 hours over one month leads to a 6+ months reduction of craving by 20% and of unhealthy consumptions by 25% (Najberg 2021; 2023). Our intervention also reduces by half early diet failures (Najberg 2024). We used the most stringent double-blind randomized control trials to demonstrate our effects in a total of more than 500 participants.
Read more

About me

Serial tech startup founder with 10+ years of experience in leading startups, with a focus on digital health solutions, and a successful exit in the field.

My organisation

Neuria developed a “digital Ozempic (GLP-1)”—just as effective, but more precise and sustainable, targeting the root cause of cravings.

Our technology is patented and backed up with three double-blind randomized clinical trials.

Social media

Speaker sessions (1)

Tuesday, 10 December 2024

10:15 - 11:20

Pitch Sessions Healthtech

Format:In-personLocation:Pitch Area 1Track:Pitch Session

Experience the forefront of healthtech innovation at EPFL Investor Day!

Marketplace (1)

  • Investment

    Seed round

    Neuria is preparing a 3Mio CHF Seed (March-April 2025) with the clear milestone to be pre-commercial in CH and USA.

    • See stage.
    • Healthcare
    • Food, Beverages and Agriculture
    Author

    Frédérik Plourde

    CEO & Co-founder at Neuria SA

    Fribourg, Switzerland